Alexion gets FDA priority review for Ultomiris in rare kidney disease

[
Alexion gets FDA priority review for Ultomiris in rare kidney disease
[og_img]
https://www.investing.com/news/stock-market-news/alexion-gets-fda-priority-review-for-ultomiris-in-rare-kidney-disease-93CH-4741224


Investing.com